Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc | 0 | 653,225 | +653,225 | 0 | 8,688 | 6.44% | +8,688 |
| Lexeo Therapeutics | 2,355,904 | 2,355,904 | 0 | 36,941 | 37,789 | 28.00% | +848 |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | 3,194 | 3,711 | 2.75% | +517 |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | 1,344 | 1,297 | 0.96% | -48 |
| Morphic Holding | 159,846 | 159,846 | 0 | 5,627 | 5,446 | 4.03% | -181 |
| Immunic Inc | 1,788,160 | 1,788,160 | 0 | 2,360 | 1,985 | 1.47% | -376 |
| Kronos Bio | 955,866 | 0 | -955,866 | 1,243 | 0 | — | -1,243 |
| enGene Holdings Inc. *W EXP 10/31/202 | 360,903 | 321,502 | -39,401 | 1,877 | 383 | 0.28% | -1,494 |
| Replimune Group(REPL) | 3,001,319 | 2,461,319 | -540,000 | 24,521 | 22,152 | 16.41% | -2,369 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 8,438 | 4,607 | 3.41% | -3,831 |
| enGene Holdings Inc. COM | 1,076,357 | 1,076,357 | 0 | 18,244 | 10,150 | 7.52% | -8,094 |
| Nuvation Bio(NUVB) | 14,072,340 | 13,275,884 | -796,456 | 51,223 | 38,766 | 28.72% | -12,458 |